JP2016527229A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016527229A5 JP2016527229A5 JP2016526997A JP2016526997A JP2016527229A5 JP 2016527229 A5 JP2016527229 A5 JP 2016527229A5 JP 2016526997 A JP2016526997 A JP 2016526997A JP 2016526997 A JP2016526997 A JP 2016526997A JP 2016527229 A5 JP2016527229 A5 JP 2016527229A5
- Authority
- JP
- Japan
- Prior art keywords
- octahydro
- dioxo
- benzamide
- trifluoromethyl
- ethenocycloprop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 14
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 7
- 229920000642 polymer Polymers 0.000 claims 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 6
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 5
- 239000006193 liquid solution Substances 0.000 claims 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 238000001816 cooling Methods 0.000 claims 3
- 238000010438 heat treatment Methods 0.000 claims 3
- -1 methyl ether ketone Chemical class 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000007962 solid dispersion Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- CSKDFZIMJXRJGH-VWLPUNTISA-N tecovirimat Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)NN1C(=O)[C@@H]([C@@H]2[C@H]3C[C@H]3[C@H]3C=C2)[C@@H]3C1=O CSKDFZIMJXRJGH-VWLPUNTISA-N 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 2
- 229920003091 Methocel™ Polymers 0.000 claims 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 229920001531 copovidone Polymers 0.000 claims 2
- LUJQXGBDWAGQHS-UHFFFAOYSA-N ethenyl acetate;phthalic acid Chemical compound CC(=O)OC=C.OC(=O)C1=CC=CC=C1C(O)=O LUJQXGBDWAGQHS-UHFFFAOYSA-N 0.000 claims 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 2
- 229960003943 hypromellose Drugs 0.000 claims 2
- 238000002844 melting Methods 0.000 claims 2
- 230000008018 melting Effects 0.000 claims 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 2
- 150000004682 monohydrates Chemical class 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 229920001983 poloxamer Polymers 0.000 claims 2
- 229960000502 poloxamer Drugs 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 229920002744 polyvinyl acetate phthalate Polymers 0.000 claims 2
- 229940069328 povidone Drugs 0.000 claims 2
- 238000000634 powder X-ray diffraction Methods 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- VOJUXHHACRXLTD-UHFFFAOYSA-N 1,4-dihydroxy-2-naphthoic acid Chemical group C1=CC=CC2=C(O)C(C(=O)O)=CC(O)=C21 VOJUXHHACRXLTD-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 229920003072 Plasdone™ povidone Polymers 0.000 claims 1
- IYKJEILNJZQJPU-UHFFFAOYSA-N acetic acid;butanedioic acid Chemical compound CC(O)=O.OC(=O)CCC(O)=O IYKJEILNJZQJPU-UHFFFAOYSA-N 0.000 claims 1
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 claims 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- FYUWIEKAVLOHSE-UHFFFAOYSA-N ethenyl acetate;1-ethenylpyrrolidin-2-one Chemical compound CC(=O)OC=C.C=CN1CCCC1=O FYUWIEKAVLOHSE-UHFFFAOYSA-N 0.000 claims 1
- UHUSDOQQWJGJQS-UHFFFAOYSA-N glycerol 1,2-dioctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC UHUSDOQQWJGJQS-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000008389 polyethoxylated castor oil Substances 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020195121A JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361856240P | 2013-07-19 | 2013-07-19 | |
| US61/856,240 | 2013-07-19 | ||
| PCT/US2014/046340 WO2015009566A1 (en) | 2013-07-19 | 2014-07-11 | Amorphous tecovirimat preparation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020195121A Division JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016527229A JP2016527229A (ja) | 2016-09-08 |
| JP2016527229A5 true JP2016527229A5 (enExample) | 2017-08-24 |
| JP6843616B2 JP6843616B2 (ja) | 2021-03-17 |
Family
ID=52346653
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016526997A Active JP6843616B2 (ja) | 2013-07-19 | 2014-07-11 | アモルファステコビリマット調製 |
| JP2020195121A Active JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
| JP2023065084A Pending JP2023080234A (ja) | 2013-07-19 | 2023-04-12 | アモルファステコビリマット調製 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020195121A Active JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
| JP2023065084A Pending JP2023080234A (ja) | 2013-07-19 | 2023-04-12 | アモルファステコビリマット調製 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9670158B2 (enExample) |
| EP (2) | EP3763702B1 (enExample) |
| JP (3) | JP6843616B2 (enExample) |
| CN (2) | CN105307636A (enExample) |
| AU (1) | AU2014290333B2 (enExample) |
| CA (3) | CA2917199C (enExample) |
| IL (1) | IL242331B (enExample) |
| WO (1) | WO2015009566A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105307636A (zh) * | 2013-07-19 | 2016-02-03 | 西佳技术公司 | 非晶形特考韦瑞制备 |
| CN107126419B (zh) * | 2016-02-26 | 2020-06-19 | 石药集团中诺药业（石家庄）有限公司 | 一种奥贝胆酸片剂及其制备方法 |
| CN112955130A (zh) * | 2018-10-30 | 2021-06-11 | 佩洛通治疗公司 | 包含取代茚满的固体分散体和药物组合物及其制备和使用方法 |
| CN115141136B (zh) * | 2021-03-31 | 2023-06-20 | 中国人民解放军军事科学院军事医学研究院 | 特考韦瑞药的共晶及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20011184A1 (es) | 2000-03-16 | 2001-11-15 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa |
| US6596771B2 (en) | 2001-01-12 | 2003-07-22 | Schering Corporation | Drugs for treating viral infections |
| US6433016B1 (en) | 2001-01-12 | 2002-08-13 | Vassil Stefanov Georgiev | Drugs for treating viral infections |
| US7687641B2 (en) | 2003-06-20 | 2010-03-30 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| PL1638938T3 (pl) | 2003-06-20 | 2017-10-31 | Siga Tech Inc | Związki, kompozycje i sposoby do leczenia i zapobiegania infekcjom ortopokswirusami i powiązanym chorobom |
| WO2006110655A2 (en) * | 2005-04-08 | 2006-10-19 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
| JP2010526848A (ja) * | 2007-05-11 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | 難溶性薬物用の医薬組成物 |
| PE20170944A1 (es) * | 2010-03-23 | 2017-07-13 | Siga Tech Inc | Formas polimorficas de st-246 y metodos de preparacion |
| RU2566716C2 (ru) * | 2010-06-09 | 2015-10-27 | Эббви Бахамаз Лтд. | Твердые дисперсии, содержащие ингибиторы киназ |
| GB201103837D0 (en) * | 2011-03-07 | 2011-04-20 | Oxagen Ltd | Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid |
| WO2012122279A1 (en) * | 2011-03-08 | 2012-09-13 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| KR102000312B1 (ko) * | 2011-10-14 | 2019-07-15 | 어레이 바이오파마 인크. | Erb2 (her2) 저해제의 고체 분산물 |
| JP2013103899A (ja) * | 2011-11-11 | 2013-05-30 | Fuji Chem Ind Co Ltd | 難溶性薬物の新規な固体分散体 |
| CN102406617B (zh) * | 2011-11-30 | 2013-08-28 | 中国人民解放军军事医学科学院生物工程研究所 | 一种替韦立马干混悬剂及其制备方法 |
| CN105307636A (zh) | 2013-07-19 | 2016-02-03 | 西佳技术公司 | 非晶形特考韦瑞制备 |
-
2014
- 2014-07-11 CN CN201480026785.8A patent/CN105307636A/zh active Pending
- 2014-07-11 EP EP20190932.2A patent/EP3763702B1/en active Active
- 2014-07-11 CA CA2917199A patent/CA2917199C/en active Active
- 2014-07-11 AU AU2014290333A patent/AU2014290333B2/en active Active
- 2014-07-11 WO PCT/US2014/046340 patent/WO2015009566A1/en not_active Ceased
- 2014-07-11 CN CN202010516675.7A patent/CN111635353A/zh active Pending
- 2014-07-11 US US14/903,083 patent/US9670158B2/en active Active
- 2014-07-11 CA CA3128535A patent/CA3128535C/en active Active
- 2014-07-11 JP JP2016526997A patent/JP6843616B2/ja active Active
- 2014-07-11 CA CA3246369A patent/CA3246369A1/en active Pending
- 2014-07-11 EP EP14825621.7A patent/EP3021836B1/en active Active
-
2015
- 2015-10-29 IL IL242331A patent/IL242331B/en active IP Right Grant
-
2017
- 2017-04-27 US US15/498,787 patent/US9889119B2/en active Active
-
2018
- 2018-01-02 US US15/860,262 patent/US10045963B2/en active Active
-
2020
- 2020-11-25 JP JP2020195121A patent/JP7681393B2/ja active Active
-
2023
- 2023-04-12 JP JP2023065084A patent/JP2023080234A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abu-Diak et al. | An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations | |
| JP2021512117A (ja) | 嚢胞性線維症を処置するための医薬組成物 | |
| JP2023080234A5 (enExample) | ||
| JP2017500332A (ja) | 経口医薬組成物 | |
| JP6470257B2 (ja) | 分散安定化剤としてポリエチレングリコール系高分子及び／またはビニルピロリドン系高分子を含むタダラフィル遊離塩基含有フィルム剤形 | |
| JP2015527395A5 (enExample) | ||
| WO2015165320A1 (zh) | 瑞戈非尼盐及其晶型、制备方法 | |
| JP2013103899A (ja) | 難溶性薬物の新規な固体分散体 | |
| WO2013120464A1 (en) | A process for the preparation of rivaroxaban based on saving of 1,1'-carbonyl diimidazole. | |
| JP2020117475A (ja) | ラメルテオン含有フィルムコーティング錠剤 | |
| CN104224754A (zh) | 一种达比加群酯药物组合物及其制备方法 | |
| Obara et al. | Properties and applications of hypromellose acetate succinate (HPMCAS) for solubility enhancement using melt extrusion | |
| WO2016135755A1 (en) | Amorphous apremilast, premixes thereof, and novel crystalline forms of apremilast | |
| WO2017056109A2 (en) | Novel forms of lumacaftor and processes for the preparation thereof | |
| WO2008034912A2 (en) | Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof | |
| CN108348617A (zh) | 用于口服用途的含有无定形索非那新的固体制剂及其制备方法 | |
| WO2016059548A1 (en) | Processes for the preparation of dabrafenib | |
| JP2012522742A (ja) | ７−［４−［４−（２，３−ジクロロフェニル）ピペラジン−１−イル］ブトキシ］−３，４−ジヒドロ−１ｈ−キノリン−２−オン塩基またはその塩もしくは水和物を含む経口フィルム | |
| CN105683187A (zh) | 吡唑并吡啶类化合物的固体形态 | |
| CN103168030B (zh) | 一种制备氨氯地平的方法 | |
| JP2020519669A5 (enExample) | ||
| CN104771376A (zh) | 一种盐酸决奈达隆片剂及其制备方法 | |
| US20170049764A1 (en) | Dosing Preparation of Dabigatran Etexilate or a Salt Thereof and a Preparation Method Thereof | |
| JP6423033B2 (ja) | 製造工程分解物の少ないイミダフェナシンを含有する造粒物 | |
| RU2021116298A (ru) | Аморфная твердая дисперсия, содержащая 6-(1-акрилоилпиперидин-4-ил)-2-(4-феноксифенил)никотинамид |